Spotlight on Testing: Detection and Documentation of In Utero Exposure to Kratom With Umbilical Cord Tissue

Originally published on November 8, 2022

Lecture Presenter

Gwendolyn A. McMillin, PhD

Professor
University of Utah School of Medicine
Scientific Director, Mass Spectrometry Platform, Medical Director, Clinical Toxicology and Pharmacogenomics
ARUP Laboratories

Dr. Gwendolyn A. McMillin is the scientific director of mass spectrometry platform at ARUP Laboratories as well as the medical director of clinical toxicology and pharmacogenomics. She is also a professor at the University of Utah School of Medicine. Dr. McMillin received her doctorate degree in pharmacology from the University of Utah, where she also completed a clinical chemistry fellowship. Dr. McMillin is board certified in clinical chemistry and toxicological chemistry. Her research interests include pharmacogenomics, newborn drug exposures, and analytical methods. She is the recipient of the Past Chair award, the Ellis Benson Young Investigator award, and the Outstanding Speaker award.

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories